Yahoo Finance

Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative ...

BEIJING and BRIDGEWATER, N.J., April 9, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (hereinafter referred to as "Gan & Lee", SSE: 603087) announced the signing of an exclusive licensing agreement ...
irblog.prnewswire.com

World GaN Electronics Patent Landscape Analysis Report 2023: Focus on Patenting Activity of US, Japanese, Chinese, European, South Korean and Taiwanese Entities

DUBLIN, Feb. 20, 2024 /PRNewswire/ -- The "GaN Electronics Patent Landscape Analysis 2023" report has been added to ResearchAndMarkets.com's offering. In this context, the GaN Electronics Patent ...
PR Newswire

Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative ...

Strategic Alliance: By Leveraging JW's Strengths in R&D and Commercialization in South Korea, Gan & Lee Will Establish a Strong Commercial Footprint in South Korea's High-Potential Metabolic Disease ...